Skip to main content
# Title Department Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023
32 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Sanaa Saber Abdelraheem Barakat 2023
33 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
34 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Dr. Doaa Fathi Hagag Ahmed 2023
35 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Department of Medical Oncology Amany Nasr Ahmed Mohammed Elemary 2023
36 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2023
37 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
38 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Amany Mohammed Abdel Moatamed 2023
39 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2022
40 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Dr. Shimaa Hassan Shabaan Hassan 2022